Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.
Clin J Am Soc Nephrol. 2010 Feb;5(2):307-13. doi: 10.2215/CJN.04430709. Epub 2010 Jan 7.
Arteriovenous fistulas (AVFs) remain the preferred vascular access for hemodialysis patients. Dialysis facilities that fail to meet Centers for Medicare & Medicaid Services goals cite patient case-mix as a reason for low AVF prevalence. This study aimed to determine the magnitude of the variability in AVF usage across dialysis facilities and the extent to which patient case-mix explains it.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The vascular access used in 10,112 patients dialyzed at 173 Dialysis Clinic Inc. facilities from October 1 to December 31, 2004, was evaluated. The access in use was considered to be an AVF if it was used for >70% of hemodialysis treatments. Mixed-effects models with a random intercept for dialysis facilities evaluated the effect of facilities on AVF usage. Sequentially adjusted multivariate models measured the extent to which patient factors (case-mix) explain variation across facilities in AVF rates.
3787 patients (38%) were dialyzed using AVFs. There was a significant facility effect: 7.6% of variation in AVF use was attributable to facility. This was reduced to 7.1% after case-mix adjustment. There were no identified specific facility-level factors that explained the interfacility variation.
AVF usage varies across dialysis facilities, and patient case-mix did not reduce this variation. In this study, 92% of the total variation in AVF usage was due to patient factors, but most were not measurable. A combination of patient factors and process indicators should be considered in adjudicating facility performance for this quality indicator.
动静脉瘘(AVF)仍然是血液透析患者首选的血管通路。未能达到医疗保险和医疗补助服务中心(Centers for Medicare & Medicaid Services)目标的透析中心将患者病例组合作为低动静脉瘘普及率的原因之一。本研究旨在确定透析中心之间动静脉瘘使用的变异性程度,以及病例组合在多大程度上解释了这种变异性。
设计、设置、参与者和测量:评估了 2004 年 10 月 1 日至 12 月 31 日期间在 173 家透析诊所公司(Dialysis Clinic Inc.)设施中接受透析的 10112 名患者使用的血管通路。如果血管通路用于超过 70%的血液透析治疗,则将其视为动静脉瘘。使用具有透析中心随机截距的混合效应模型评估了中心对动静脉瘘使用的影响。顺序调整的多变量模型衡量了患者因素(病例组合)在动静脉瘘率方面解释中心间差异的程度。
3787 名患者(38%)使用动静脉瘘进行透析。存在显著的中心效应:7.6%的动静脉瘘使用率差异归因于中心。在病例组合调整后,这一比例降低至 7.1%。没有发现特定的中心层面因素可以解释中心间的差异。
动静脉瘘的使用在透析中心之间存在差异,而患者病例组合并不能减少这种差异。在这项研究中,动静脉瘘使用率的总变异中有 92%归因于患者因素,但大多数因素是不可测量的。在判断该质量指标的中心绩效时,应综合考虑患者因素和过程指标。